19 June 2026

Clinical Diabetes Obesity Pharmaceuticals

Tirzepatide KwikPen update: Practical guidance for clinicians

11 June 2026

Clinical Diabetes Obesity Pharmaceuticals

How do people feel about using GLP-1 RAs?

9 June 2026

Diabetes Political

Anti-MAHA docs kicked out of American Diabetes Association conference

5 June 2026

Clinical Diabetes

Coming up: Practical guide to improving control of T2D

4 June 2026

Clinical research Diabetes Respiratory

Diabetes doubles down on bronchiectasis burden

27 May 2026

Diabetes Pharmaceuticals

TGA green light for first drug to slow type 1 diabetes

4 May 2026

Cardiovascular Diabetes Obesity Research

A potential new way to target excess glycogen stores

25 April 2026

Diabetes Pharmaceuticals

PBAC says yes to tirzepatide for T2D – but Lilly says no

10 April 2026

Clinical Diabetes Research

Diabetes referrals lost in the fog says new study

2 April 2026

Clinical Diabetes Pharmaceuticals

An update on semaglutide for CKD in the presence of T2D

10 March 2026

Clinical Diabetes Renal

Coming up: the role of GLP-1 in the management of CKD in T2D

27 February 2026

Diabetes Pharmaceuticals TGA

Two oral GLP-1 RAs go head-to-head

26 February 2026

Diabetes Endocrinology Haematology

Metabolic blockbusters enter the bloodstream

6 February 2026

Clinical Diabetes Physiotherapy Renal

CKD in diabetes: What clinicians need to check early

2 February 2026

Clinical Diabetes Renal

From screening to action: practical CKD tips

8 December 2025

Diabetes Pharmaceuticals Weight management

Oral GLP1 hits big numbers in global trial